| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.00044 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.00057 | 1 |